West LA Times

GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE® platform, today announced that Dr. Jeffrey Miller, MD, GT Bipharma’s Consulting Chief Medical Officer and Chief Scientific Officer, will present a corporate overview at H.C. Wainwright’s Cell Therapy Virtual Conference taking place on February 28, 2023. Company management will also be participating in 1x1 meetings during the event.

H.C. Wainwright Cell Therapy Virtual Conference – February 28, 2023
Title:	GT Biopharma (GTBP) Company Presentation
Date:	Tuesday, February 28, 2023
Time:	9:00 – 9:20 am ET
Presenter:	Dr. Jeffrey Miller, MD, Consulting CMO & CSO, GT Biopharma
Webcast Link:	Register here

If you are interested in arranging a 1x1 meeting request with management, please contact your H.C. Wainwright representative.

Original source can be found here.